Abiopharma

🔍 Cornehl Lisa W (Executive)

Company: First American Financial Corp (FAF)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Sold 5,823 shares of Common Stock at $68.627 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 29,635.49 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.61 to $68.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F2: Includes 2,437 unvested Restricted Stock Units ("RSUs") acquired pursuant to an original grant of 6,734 RSUs and shares acquired through automatic dividend reinvestment, which vest in three equal annual increments commencing 2/22/2025, the first anniversary of the grant.
• F3: Includes 6,566 unvested RSUs acquired pursuant to an original grant of 9,432 RSUs and shares acquired through automatic dividend reinvestment, which vest in three equal annual increments commencing 2/24/2026, the first anniversary of the grant.
• F4: Includes 886 unvested RSUs acquired pursuant to an orignal grant of 865 RSUs and shares acquired through automatic dividend reinvestment, which vest in three equal annual increments commencing 6/20/2026, the first anniversary of the grant.
• F5: Includes 12,176 unvested RSUs acquired pursuant to an original grant of 12,076 RSUs and shares acquired through automatic dividend reinvestment, which vest in three equal annual increments commencing 2/19/2027, the first anniversary of the grant.